I spent some time with my friend Milind Shah, who leads Strategy and Digital Solutions at Elevance Health, and he drops wisdom and insights on the state of transformation in healthcare and the role of digital and AI. Take a listen, Milind blends business insights with technology applications and goes really deep in some areas!

About Milind:

Milind has been in the healthcare industry for over 15 years now and truly enjoys having the opportunity to be a part of having an impact on the industry and truly leaving a legacy. He currently leading up Strategy & Solutions for Carelon Digital Platforms, supporting the overall vision of transforming the company, with a focus on Digital products & solutions focusing on both the Member and Provider. He is responsible for partnering across the enterprise to define the overall Digital focus aligned to the Enterprise strategic priorities, driving Carelon growth/commercialization, and identifying acceleration opportunities through strategic partnerships, while also partnering with Corp Dev on M&A opportunities. A lot of his focus currently is partnering across the Enterprise on areas like transformation through AI and looking at opportunities to leverage the robust “ecosystem” that is being invested in to help accelerate impact at scale for Elevance Health. Throughout his career, Milind has built and led teams that focus on Transformation, Innovation, and Strategy with an emphasis on Growth Strategy, M&A, Post Merger Integration, and Disruptive/Exponential Product and he’s had some great opportunities to do things like running Innovation Studios at Salesforce to being a part of the Senior Leadership team at Humana to help with several of their transformation initiatives as the company moved to focusing on their Growth Strategy.

Find him at: LinkedIn: https://www.linkedin.com/in/milinds/

In this episode, I chat with my good friend, Akshay Sharma, Chief AI Officer at Lyric. In this episode, we tackle the topics of AI healthcare solutions and just how the landscape is set to be disrupted by AI. Akshay is a wealth of knowledge and experience in disrupting traditional industries like healthcare and financial services with AI and crypto and he really brought an amazing perspective to this topic. I hope you enjoy this episode, and please like and subscribe!

In this episode, I am joined by the amazing Walter De Brouwer. We dive deep into understanding AI as it co-inhabits our lives alongside humans! It raises new questions, new interaction patterns and new experiences and Walter discussed how to think about AI, treat AI and what AGI will do.

Walter's Bio:

Walter De Brouwer (WDB) has established several AI and deep tech companies (1990-now), 2 of which have undergone public offerings in Europe (LSE, Euronext) and 2 in the USA (NYSE, NASDAQ). His latest AI company merged with Atlanta-based ShareCare [NASDAQ: SHCR] and went IPO at a valuation of $3.9B (July 2, 2021). At Sharecare he serves as the Chief Scientific Officer. WDB holds a PhD in computational semiotics and has been a professor at Stanford University since 2018 where he is the course director of MED-205.

He is an active contributor and beta tester of Generative AI projects, LLMs and Agent architectures. His research interests are in Multimodal Transformers, AGI, GPT agents and 6G. He is the author of 53 patents. WDB is a General Partner at Claritas Capital (Nashville, since January 2022), a $1B PE fund where he runs the Media and Entertainment (Claritas M&E) sector. Walter De Brouwer is a member of the Recording Academy (Grammy’s), a senior member of the Institute of Electrical and Electronics Engineers (IEEE), the American Mathematical Society (AMS) and the Army and Navy Officers Club of Washington, D.C. He resides with his family in Malibu, CA.

Find Walter here:

Walter's Ted AI talk: https://www.ai-event.ted.com/speakers-1/walter-de-brouwer-/computational-linguist--

LinkedIn: https://www.linkedin.com/in/wdebrouwer/

X: https://twitter.com/walterdebrouwer

In this new episode of the Stories in AI podcast, I sit down with the Architect of Ethical AI Practice at Salesforce, Yoav Schlesinger. Yoav gives us a great look at how large industry players like Salesforce are implementing AI, looking ahead at future AI developments, and managing all the risks that come with managing large swaths of data.

About Yoav:

Yoav Schlesinger is an Architect of Ethical AI Practice at Salesforce, helping the company embed and instantiate ethical product practices to maximize the societal benefits of AI. Prior to coming to Salesforce, Yoav was a founding member of the Tech and Society Solutions Lab at Omidyar Network, where he launched the Responsible Computer Science Challenge and helped develop EthicalOS, a risk mitigation toolkit for product managers. Find him at: LinkedIn: https://www.linkedin.com/in/yschlesinger/

I am joined, once again, by my good friend Sanjay Srivastava, SVP & CDO of Genpact. In this episode, Sanjay and I chat about AI from the perspective of enterprises. We dive deep into how AI hit a turning point, developing unique AI solutions for businesses, and how to get started in the field. Hope you enjoy the discussion as much as we did.

About Sanjay: Sanjay Srivastava is senior vice president and chief digital officer at Genpact, a global digital transformation services provider. He runs the company’s Data, AI, Analytics, Automation Software, and Technology Services businesses and oversees Genpact’s AI-enabled digital business platform, Cora.

Sanjay is deeply rooted in the innovation ecosystem and is an advisor to Silicon Valley incubators and several startups, and a limited partner in digital-focused venture funds. Sanjay serves on the MMA CDO Board, is a member of the Digital 50, BCG’s Digital Transformation Network, and CNBC’s Technology Executive Council was named IDG “Top 10 Digital Transformation Influencers to Follow”, and blogs frequently on LinkedIn. Prior to Genpact, Sanjay was a serial entrepreneur, and built four startups - in edge networks, data center automation, predictive algorithms, and enterprise SaaS that were acquired by Akamai, BMC, SunGard (now FIS), and Genpact, respectively. He also held operating leadership roles at Hewlett Packard, Akamai, and SunGard, where he oversaw product management, global sales, and various product and services P&Ls.

Sanjay earned an M.B.A. from the University of Minnesota-Twin Cities and his undergraduate degree at the Indian Institute of Technology, Kharagpur. He is based in Seattle, WA.

Find him here:

LinkedIn: https://www.linkedin.com/in/sanjaysrivastava/

Twitter: https://twitter.com/SanjayAndAI

Had an amazing conversation with Eugenio Zuccarelli, Data Scientist Manager at CVS Health. In this episode, we talk about why large language models are all the hype, and how they will be used to transform the healthcare industry. Eugenio also gives valuable insight into his career as a data scientist, and the keys to climbing the ladder of success.

Bio:

Eugenio is a Business-Focused Data Science Leader, driving the innovation efforts for several Fortune 500 companies across multiple industries, including Healthcare (CVS Health), Automotive (BMW) and Finance (Morningstar). He is a Forbes 30 Under 30, a Fulbright Scholarship recipient and studied across MIT, Harvard and Imperial College. Currently, he leads the innovation efforts for complex chronic care at CVS Health, the #1 Healthcare company in the world and a Fortune 5 firm.

In addition, he has been working in the Task Force using analytics to fight COVID-19 and develop policy recommendations for The White House and overall finding solutions to fight the COVID-19 pandemic. You can find Eugenio's work across Forbes, The Washington Post, Bloomberg and Financial Times as well as multiple journals and in the App Store.

Previously, Eugenio worked as Data Scientist at Dr Foster - Telstra Health, a leading Fortune 500 healthcare analytics firm based in London working closely to the NHS, after having worked as Data Analyst for a fintech startup, Arkera.

He obtained a Master of Business Analytics from MIT, a Master of Science in Biomedical Engineering with Neurotechnology from Imperial College London. While at MIT, he worked as a Researcher at the MIT Operations Research Center and at the MIT Media Lab, while at Imperial College he worked at the Brain & Behaviour Lab under the supervision of Prof. Aldo Faisal, developing state-of-the-art prosthetic technologies as a member of Team Imperial to participate in the first Bionics Olympics, Cybathlon.

Previously, he received a Bachelor of Science in Electronic and Information Technology Engineering from the University of Genoa in Italy.

Amir Emadzadeh, Director of Data Science at Genentech, talks about the massive impact natural language processing and generative AI will have on the healthcare industry. We speak specifically about different use cases in life sciences to accelerate drug discovery and getting better treatments to patients.

Amir's Bio

Amir Emadzadeh holds a PhD in Electrical Engineering from the University of California at Los Angeles (UCLA). Over his 13 years of work experience, he has been granted an equal number of patents while at top Silicon Valley companies, including Qualcomm, Nvidia, and Google (Waymo). He is a Director of software in the Digital Transformation Office (DTO) at Genentech (Roche). He is also an adjunct Professor at California Science and Technology University (CSTU). Most recently, he was a Director of data science at Gilead sciences, where he led a team of data scientists and software developers dedicated to improving different aspects of clinical trials. Amir is very passionate about employing AI/ML techniques and automation to tackle pharma/healthcare industry challenges. Some of his recent work includes data-driven feasibility analysis for clinical trials (e.g., clinical trial site/investigator ranking, country assessment, diversity analysis & patient enrollment forecasting), extracting insights from clinical trial documents and sentiment analysis using NLP technology, and medical image segmentation/classification using deep neural networks.

Find Amir on: LinkedIn: https://www.linkedin.com/in/amiremadzadeh/

I had an amazing discussion with Amr Awadallah, CEO and Founder of Vectara. In this episode, we dive deep into what is really going on behind the scenes with AI? We discuss topics like the opportunities, the fear of AI and how much potential AI growth still has. If you want an expert opinion on all the latest debates and issues surrounding AI, this is the episode for you.

Amr Bio:

Amr is the CEO and Founder of Vectara. Prior to founding Vectara, Amr served as the VP of Developer Relations for Google Cloud. Amr co-founded Cloudera, where he led the development of enterprise tools to ingest and extract value from big data. Before Cloudera, Amr served as VP of product intelligence engineering at Yahoo after Yahoo acquired his first startup Aptiva, a search engine company. Amr holds a Ph.D. in Electrical Engineering from Stanford University and a MA from Cairo University. You can reach Amr at https://www.linkedin.com/in/awadallah/